2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol

C25H38N6O — CID 168903871

IUPAC2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol
SMILESCCC(CCNC)C(C)(C)N1C2CCC1CN(c1cc(-c3ccccc3O)nnc1N)C2
InChIInChI=1S/C25H38N6O/c1-5-17(12-13-27-4)25(2,3)31-18-10-11-19(31)16-30(15-18)22-14-21(28-29-24(22)26)20-8-6-7-9-23(20)32/h6-9,14,17-19,27,32H,5,10-13,15-16H2,1-4H3,(H2,26,29)
InChIKeyKHNQMUHULMVMFW-UHFFFAOYSA-N
MW438.62 g/mol
LogP3.50
Rot. Bonds8

About 2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol

2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol (PubChem CID 168903871) has the molecular formula C25H38N6O and a molecular weight of 438.62 g/mol. Its IUPAC name is 2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol.

Molecular Properties

Compound Name2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol
PubChem CID168903871
Molecular FormulaC25H38N6O
Molecular Weight438.62 g/mol
Exact Mass438.31
IUPAC Name2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol
SMILESCCC(CCNC)C(C)(C)N1C2CCC1CN(c1cc(-c3ccccc3O)nnc1N)C2
InChIInChI=1S/C25H38N6O/c1-5-17(12-13-27-4)25(2,3)31-18-10-11-19(31)16-30(15-18)22-14-21(28-29-24(22)26)20-8-6-7-9-23(20)32/h6-9,14,17-19,27,32H,5,10-13,15-16H2,1-4H3,(H2,26,29)
InChIKeyKHNQMUHULMVMFW-UHFFFAOYSA-N
XLogP3.50
TPSA90.54 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500438.62
LogP ≤ 53.50
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Analyze 2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol?
The IUPAC name of 2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol (CID 168903871) is 2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol.
What is the SMILES notation for 2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol?
The canonical SMILES for 2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol is CCC(CCNC)C(C)(C)N1C2CCC1CN(c1cc(-c3ccccc3O)nnc1N)C2.
What is the InChIKey of 2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol?
The InChIKey is KHNQMUHULMVMFW-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H38N6O/c1-5-17(12-13-27-4)25(2,3)31-18-10-11-19(31)16-30(15-18)22-14-21(28-29-24(22)26)20-8-6-7-9-23(20)32/h6-9,14,17-19,27,32H,5,10-13,15-16H2,1-4H3,(H2,26,29).
What are the key properties of 2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol?
2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol has a molecular weight of 438.62 g/mol, XLogP of 3.50, 8 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[6-amino-5-[8-[3-ethyl-2-methyl-5-(methylamino)pentan-2-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol is sourced from PubChem (CID 168903871), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).